BUY IPCA Laboratories Limited — Kunal Saraogi
byKunal SaraogiHorizon: 1–3 months23 Oct 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·23 Oct · today
Ipca Laboratories stock reports stronger Q1 growth as guidance rises
NewsGoogle News·7 Oct · 2w ago
2 other SEBI-registered advisors have active short-term BUY calls on this stock
Advisor consensus · same horizon·18 Aug · 2mo ago
MACD below its signal line — bearish momentum
Technicals · macd·23 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
- BUY — Vikas Sethi, Sethi Finmart1 Oct 2026 · ~2 weeks · target ₹1,990 · SL hit
More from Kunal Saraogi
- BUY Firstsource Solutions23 Oct 2026 · ~2 weeks · target ₹299 · SL hit
- BUY L&T Technology Services22 Oct 2026 · ~2 weeks · target ₹4,600 · Active
- BUY Persistent Systems22 Oct 2026 · Same day · target ₹6,000 · SL hit
- BUY Oil India21 Oct 2026 · ~2 weeks · target ₹480 · Active
- BUY Nuvama Wealth Management21 Oct 2026 · ~1 year · target ₹2,100 · Active

